Biosimilar Newsletter Archive

1. 09.11.25 -- How AI Is Revolutionizing Quality Management Systems 9/11/2025
   09/11/25 Biosimilar Development Newsletter
2. 09.04.25 -- Learn how to enhance productivity in your monoclonal antibody (mAb) capture process 9/4/2025
   09/04/25 Biosimilar Development Newsletter
3. 09.04.25 -- Accelerate Process Development With Automated Aseptic Sampling 9/4/2025
   09/04/25 Biosimilar Development Newsletter
4. 08.28.25 -- The Building Blocks Of A Robust Analytical Assay 8/28/2025
   08/28/25 Biosimilar Development Newsletter
5. 08.21.25 -- Production Of A Highly Concentrated mAb 8/21/2025
   08/21/25 Biosimilar Development Newsletter
6. 08.14.25 -- Preparing For FDA's Expanded Use Of Unannounced Inspections At Foreign Facilities 8/14/2025
   08/14/25 Biosimilar Development Newsletter
7. 08.07.25 -- Unlocking Value In Biopharma Operations: A C-Suite Call To Action 8/7/2025
   08/07/25 Biosimilar Development Newsletter
8. 07.31.25 -- Navigating FDA Regulatory Changes 7/31/2025
   07/31/25 Biosimilar Development Newsletter
9. 07.25.25 -- Tools For Smarter Antibody Discovery 7/25/2025

   07/25/25 Biosimilar Development Newsletter

10. 07.17.25 -- Bracing For The Impact Of The Federal Workforce Reduction 7/17/2025
    07/17/25 Biosimilar Development Newsletter